Mostrar el registro sencillo del ítem

dc.contributor.authorBurgos-Molina, Antonio Manuel 
dc.contributor.authorPeinado-Ruiz, Isabel C.
dc.contributor.authorGonzález Vidal, Alejandro
dc.contributor.authorRuiz-Gómez, Miguel José 
dc.date.accessioned2022-12-21T07:50:45Z
dc.date.available2022-12-21T07:50:45Z
dc.date.issued2022
dc.identifier.urihttps://hdl.handle.net/10630/25653
dc.description.abstractAll tumour studied show an increase in resistance to treatment and an increase in cell survival. This response is related to an increase in the heat shock protein HSP90, since it participates in the assembly of telomerase, causing telomeres not to be shortened and leading to a longer cell life. When an HSP90 inhibitor is administered together with the usual treatment of this type of tumours, a decrease in cell survival and resistance to the antineoplastic treatment was observed. Recent scientific and clinical data show that HSP90 inhibitors strongly affect the survival of cancer cells and their use in combination with anticancer agents makes it possible to postpone cellular resistance to chemotherapy.es_ES
dc.description.sponsorshipUniversidad de Málaga. Campus de Excelencia Internacional Andalucía Tech.es_ES
dc.language.isoenges_ES
dc.rightsinfo:eu-repo/semantics/openAccesses_ES
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subjectTumores - Investigaciónes_ES
dc.subject.otherHeat shock protein inhibitorses_ES
dc.subject.otherTumour survivales_ES
dc.subject.otherHSP90 inhibitorses_ES
dc.titleExposure of cancer cells to heat shock protein inhibitors induces decreased tumour survivales_ES
dc.typeinfo:eu-repo/semantics/conferenceObjectes_ES
dc.centroFacultad de Medicinaes_ES
dc.relation.eventtitle18th ASEICA INTERNATIONAL CONGRESSes_ES
dc.relation.eventplaceSantiago de Compostela, España.es_ES
dc.relation.eventdate16 al 18 de Noviembre 2022es_ES
dc.rights.ccAttribution-NonCommercial-NoDerivatives 4.0 Internacional*


Ficheros en el ítem

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Attribution-NonCommercial-NoDerivatives 4.0 Internacional
Excepto si se señala otra cosa, la licencia del ítem se describe como Attribution-NonCommercial-NoDerivatives 4.0 Internacional